Novavax (NVAX) Dips More Than Broader Markets: What You Should Know Zacks Equity Research - Zacks - Fri Jan 15, 4:50PM CST Zacks Equity Research - ZACKS - Fri Jan 15, 4:50PM CST
In the latest trading session, Novavax (NVAX) closed at $127.43, marking a -1.96% move from the previous day.
Orchard (ORTX) Gets FDA's RMAT Status for Gene Therapy in MLD Zacks Equity Research - Zacks - Fri Jan 15, 7:36AM CST Zacks Equity Research - ZACKS - Fri Jan 15, 7:36AM CST
The FDA bestows a Regenerative Medicine Advanced Therapy status on Orchard Therapeutics' (ORTX) investigational gene therapy, OTL-200, for treating early-onset metachromatic leukodystrophy. Shares up.
Make a Fortune With These 4 High Earnings Yield Picks Rimmi Singhi - Zacks - Fri Jan 15, 7:18AM CST Rimmi Singhi - ZACKS - Fri Jan 15, 7:18AM CST
While comparing stocks, if other factors are similar, investors can look out for the one with higher earnings yield. Stocks including GM, WGO, NVAX and MT score high in that parameter.
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer Globe Newswire - Fri Jan 15, 7:01AM CST CMTX - Fri Jan 15, 7:01AM CST
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...
Is Vaccine Stock Novavax Still a Buy? stocknews.com - Wed Jan 13, 1:31PM CST STOCKNEWS - Wed Jan 13, 1:31PM CST
Vaccine specialist Novavax (NVAX) has experienced a steep decline over the past couple of months owing to the delay in its COVID-19 vaccine development. Unfortunately, the delay comes at a time when its...
3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic Ekta Bagri - Zacks - Wed Jan 13, 8:42AM CST Ekta Bagri - ZACKS - Wed Jan 13, 8:42AM CST
3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic
ERYTECH Pharma (ERYP) Catches Eye: Stock Jumps 7.4% Zacks Equity Research - Zacks - Wed Jan 13, 7:36AM CST Zacks Equity Research - ZACKS - Wed Jan 13, 7:36AM CST
ERYTECH Pharma (ERYP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Flat Session Gets Market Back in the Green Jim Giaquinto - Zacks - Wed Jan 13, 12:15AM CST Jim Giaquinto - ZACKS - Wed Jan 13, 12:15AM CST
Flat Session Gets Market Back in the Green
Is the Options Market Predicting a Spike in Novavax (NVAX) Stock? Zacks Equity Research - Zacks - Tue Jan 12, 7:54AM CST Zacks Equity Research - ZACKS - Tue Jan 12, 7:54AM CST
Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.
Halberd Corporation's Covid-19 Efforts Recognized in Wall Street PR News Article ACCESSWIRE - Tue Jan 12, 7:00AM CST CMTX - Tue Jan 12, 7:00AM CST
JACKSON CENTER, PA / ACCESSWIRE / January 12, 2021 / Halberd Corp. (OTC PINK:) was recently included alongside Novavax Inc and Moderna Inc in a recent Wall Street PR on Covid-19 related stocks poised...
Emergent (EBS) Posts Preliminary '20 Results, Gives 2021 View Zacks Equity Research - Zacks - Mon Jan 11, 8:22AM CST Zacks Equity Research - ZACKS - Mon Jan 11, 8:22AM CST
Emergent (EBS) tightens revenue view for 2020 and expects a consistent rise in sales of contract development and manufacturing services provided to other companies.
3 Biotech Stocks Worth Adding to Your Portfolio in 2021 Ekta Bagri - Zacks - Fri Jan 8, 8:05AM CST Ekta Bagri - ZACKS - Fri Jan 8, 8:05AM CST
We highlight a few biotech companies, which outperformed the sector in 2020 and are likely to witness a winning run in the near term.
Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine GlobeNewswire - Thu Jan 7, 5:14PM CST CMTX - Thu Jan 7, 5:14PM CST
-- Advance Purchase Agreement signed for NVX-CoV2373, Novavax' adjuvanted protein vaccine candidate
Novavax Inc Rises 2.71% on Heavy Volume: Watch For Potential Pullback Comtex SmarTrend(R) - Wed Jan 6, 12:18PM CST CMTX - Wed Jan 6, 12:18PM CST
Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $114.50 to a high of $120.40. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of...
Novavax to Participate in Upcoming Conferences GlobeNewswire - Wed Jan 6, 8:00AM CST CMTX - Wed Jan 6, 8:00AM CST
Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences....
The New Strain of Virus Reportedly Hit New York Baystreet.ca - Baystreet - Wed Jan 6, 6:44AM CST Baystreet.ca - BAYSTREET - Wed Jan 6, 6:44AM CST
Pandemic cases are still mounting. At the moment, there are 85.5 million cases around the world, ...
Some of the Top Pharmaceutical Companies to Watch in New Year 2021 Baystreet.ca - Baystreet - Wed Jan 6, 6:42AM CST Baystreet.ca - BAYSTREET - Wed Jan 6, 6:42AM CST
“Glioblastoma is the most common and aggressive cancerous brain tumour in adults due to its resistance ...
After Yesterday's Decline of 4.80%, Novavax Inc Offers Investors Better Value Comtex SmarTrend(R) - Thu Dec 31, 10:52AM CST CMTX - Thu Dec 31, 10:52AM CST
Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $112.55 to a high of $119.00. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $113.75...
Biotech Stock Roundup: REGN Provides COVID-19 Updates, MYOV Partners With PFE & More Zacks Equity Research - Zacks - Wed Dec 30, 10:40AM CST Zacks Equity Research - ZACKS - Wed Dec 30, 10:40AM CST
The biotech sector was in focus last week with COVID-19 vaccine study update from Novavax (NVAX) and antibody cocktail treatment update from Regeneron (REGN).
Novavax (NVAX) Initiates Phase III Study on COVID-19 Vaccine Zacks Equity Research - Zacks - Tue Dec 29, 9:12AM CST Zacks Equity Research - ZACKS - Tue Dec 29, 9:12AM CST
Novavax (NVAX) initiates phase III study on its coronavirus vaccine, NVX-CoV2373, in the United States and Mexico.
